tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Schwartz, 313 are a BUY (85.05%), 52 are a HOLD (14.13%), 3 are a SELL (0.82%).
Analyst Joseph Schwartz, currently employed at LEERINK, carries an average stock price target met ratio of 59.55% that have a potential upside of 41.44% achieved within 366 days.
Joseph Schwartz’s has documented 724 price targets and ratings displayed on 64 stocks. The coverage is on Healthcare, Energy, Financial Services sectors.
Most recent stock forecast was given on LRMR, Larimar Therapeutics at 14-Sep-2026.
Analyst best performing recommendations are on RETA (REATA PHARMACEUTICALS).
The best stock recommendation documented was for RETA (REATA PHARMACEUTICALS) at 10/14/2019. The price target of $180 was fulfilled within 4 days with a profit of $79.41 (78.94%) receiving and performance score of 197.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Oct-2020
$13.75
$14
6 years 5 days ago
(05-Oct-2020)
10/15 (66.67%)
$0.67 (5.12%)
51
Hold Since 02-Oct-2020
$13.75
$14
6 years 8 days ago
(02-Oct-2020)
4/7 (57.14%)
$0.01 (0.07%)
109
Hold Since 12-Jun-2015
$10
6 years 1 months 21 days ago
(19-Aug-2020)
7/10 (70%)
$-0.63 (-5.93%)
139
Hold Since 18-Aug-2020
$10
$-3.75 (-27.27%)
$20
6 years 1 months 22 days ago
(18-Aug-2020)
1/4 (25%)
$-0.63 (-5.93%)
6
Hold Since 21-May-2018
$10
$-3.75 (-27.27%)
6 years 2 months 3 days ago
(07-Aug-2020)
1/3 (33.33%)
$-0.55 (-5.21%)
17
Which stock is Joseph Schwartz most bullish on?
Which stock is Joseph Schwartz most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?
